CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 256 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,262,857 | -65.5% | 41,897 | -56.5% | 0.01% | -64.3% |
| Q1 2024 | $6,557,469 | -53.6% | 96,207 | -57.4% | 0.01% | -53.3% |
| Q4 2023 | $14,128,820 | +88.7% | 225,700 | +36.8% | 0.03% | +50.0% |
| Q3 2023 | $7,489,350 | -30.8% | 165,000 | -14.5% | 0.02% | -37.5% |
| Q2 2023 | $10,829,406 | -46.8% | 192,900 | -57.2% | 0.03% | -27.3% |
| Q1 2023 | $20,367,069 | +15.0% | 450,300 | +3.4% | 0.04% | -12.0% |
| Q4 2022 | $17,711,205 | -41.5% | 435,700 | -5.9% | 0.05% | -45.7% |
| Q3 2022 | $30,257,000 | +49.7% | 463,000 | +39.2% | 0.09% | +41.5% |
| Q2 2022 | $20,206,000 | +35.3% | 332,500 | +39.7% | 0.06% | +38.3% |
| Q1 2022 | $14,939,000 | +173.9% | 238,000 | +230.6% | 0.05% | +161.1% |
| Q4 2021 | $5,455,000 | -40.0% | 71,993 | -11.4% | 0.02% | -45.5% |
| Q3 2021 | $9,098,000 | -29.9% | 81,282 | +1.4% | 0.03% | -35.3% |
| Q2 2021 | $12,979,000 | +63.4% | 80,172 | +23.0% | 0.05% | +45.7% |
| Q1 2021 | $7,944,000 | +153.2% | 65,200 | +218.0% | 0.04% | +150.0% |
| Q4 2020 | $3,138,000 | +207.6% | 20,500 | +68.0% | 0.01% | +180.0% |
| Q3 2020 | $1,020,000 | +7.6% | 12,200 | -5.4% | 0.01% | -16.7% |
| Q2 2020 | $948,000 | -15.0% | 12,900 | -51.0% | 0.01% | -33.3% |
| Q1 2020 | $1,115,000 | -82.3% | 26,300 | -74.5% | 0.01% | -79.1% |
| Q4 2019 | $6,287,000 | +133.8% | 103,218 | +57.3% | 0.04% | +95.5% |
| Q3 2019 | $2,689,000 | +34.0% | 65,615 | +54.0% | 0.02% | +29.4% |
| Q2 2019 | $2,007,000 | +260.3% | 42,600 | +173.1% | 0.02% | +240.0% |
| Q1 2019 | $557,000 | -73.0% | 15,600 | -78.4% | 0.01% | -64.3% |
| Q4 2018 | $2,063,000 | +1189.4% | 72,191 | +1905.3% | 0.01% | +1300.0% |
| Q3 2018 | $160,000 | – | 3,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |